How do you manage dysgeusia from Enfortumab Vedotin?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

What is your preferred treatment for a patient with refractory metastatic upper tract urothelial carcinoma previously treated with adjuvant gemcitabine/cisplatin, enfortumab vedotin + pembrolizumab, docetaxel and sacituzumab govitecan?

1

Do the results of IMvigor011 influence you to utilize ctDNA to guide all adjuvant IO in MIBC?

1 Answers

Which patients are you utilizing subcutaneous PD-1/L1 inhibitors instead of the intravenous formulation?

1 Answers

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service